NO20042365L - Kombinasjonsterapi omfattende ZD6474 og et taxan - Google Patents

Kombinasjonsterapi omfattende ZD6474 og et taxan

Info

Publication number: NO20042365L
Authority: NO; Norway
Prior art keywords: taxane; combination therapy; therapy; combination
Prior art date: 2001-11-08

Application number

NO20042365A

Other languages

English (en)

Other versions

NO328048B1 (no

Inventor

Stephen Robert Wedge

Original Assignee

Astrazeneca Ab Global Ip

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-08

Filing date

2004-06-07

Publication date

2004-06-07

2004-06-07 Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip

2004-06-07 Publication of NO20042365L publication Critical patent/NO20042365L/no

2009-11-16 Publication of NO328048B1 publication Critical patent/NO328048B1/no

Links

229940123237 Taxane Drugs 0.000 title 1
238000002648 combination therapy Methods 0.000 title 1
DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20042365A 2001-11-08 2004-06-07 Farmasoytisk preparat omfattende ZD6474 og et taxan, sett omfattende samme samt anvendelse av samme for fremstilling av medikament for behandling av sykdom NO328048B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0126879.6A GB0126879D0 (en)	2001-11-08	2001-11-08	Combination therapy
PCT/GB2002/005021 WO2003039551A1 (en)	2001-11-08	2002-11-06	Combination therapy comprising zd6474 and a taxane

Publications (2)

Publication Number	Publication Date
NO20042365L true NO20042365L (no)	2004-06-07
NO328048B1 NO328048B1 (no)	2009-11-16

Family

ID=9925430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042365A NO328048B1 (no)	2001-11-08	2004-06-07	Farmasoytisk preparat omfattende ZD6474 og et taxan, sett omfattende samme samt anvendelse av samme for fremstilling av medikament for behandling av sykdom

Country Status (22)

Country	Link
US (2)	US20050043395A1 (no)
EP (1)	EP1446124B1 (no)
JP (1)	JP4694127B2 (no)
KR (1)	KR100959607B1 (no)
CN (1)	CN1298328C (no)
AR (1)	AR037346A1 (no)
AT (1)	ATE335488T1 (no)
AU (1)	AU2002337382B2 (no)
BR (1)	BR0213906A (no)
CA (1)	CA2464758C (no)
CY (1)	CY1106259T1 (no)
DE (1)	DE60213845T2 (no)
DK (1)	DK1446124T3 (no)
ES (1)	ES2269769T3 (no)
GB (1)	GB0126879D0 (no)
IL (2)	IL161744A0 (no)
MX (1)	MXPA04004355A (no)
NO (1)	NO328048B1 (no)
NZ (1)	NZ532525A (no)
PT (1)	PT1446124E (no)
WO (1)	WO2003039551A1 (no)
ZA (1)	ZA200403455B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL203782B1 (pl)	1999-11-05	2009-11-30	Astrazeneca Ab	Pochodne chinazoliny,sposoby ich wytwarzania,ich kompozycje farmaceutyczne oraz ich zastosowania
GB0008269D0 (en)	2000-04-05	2000-05-24	Astrazeneca Ab	Combination chemotherapy
AU779695B2 (en)	2000-04-07	2005-02-10	Astrazeneca Ab	Quinazoline compounds
DK1474420T3 (da)	2002-02-01	2012-05-21	Astrazeneca Ab	Quinazolinforbindelser
TW200813014A (en) *	2002-03-28	2008-03-16	Astrazeneca Ab	Quinazoline derivatives
GB0218526D0 (en) *	2002-08-09	2002-09-18	Astrazeneca Ab	Combination therapy
GB0223380D0 (en) *	2002-10-09	2002-11-13	Astrazeneca Ab	Combination therapy
NZ539408A (en)	2002-11-04	2007-09-28	Astrazeneca Ab	Quinazoline derivatives as SRC tyrosine kinase inhibitors for treating solid tumours
ATE506062T1 (de) *	2003-02-13	2011-05-15	Astrazeneca Ab	Kombinationstherapie von zd6474 mit 5-fu oder/und cpt-11
GB0310401D0 (en) *	2003-05-07	2003-06-11	Astrazeneca Ab	Therapeutic agent
EP1648465B1 (en) *	2003-07-10	2010-08-25	AstraZeneca AB	Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
EP1691809A1 (en) *	2003-11-14	2006-08-23	Pharma Mar, S.A.	Combination therapy comprising the use of et-743 and paclitaxel for treating cancer
GB0406445D0 (en) *	2004-03-23	2004-04-28	Astrazeneca Ab	Combination therapy
GB0411378D0 (en) *	2004-05-21	2004-06-23	Astrazeneca Ab	Pharmaceutical compositions
WO2006002422A2 (en) *	2004-06-24	2006-01-05	Novartis Vaccines And Diagnostics Inc.	Compounds for immunopotentiation
AU2005288737B2 (en) *	2004-09-27	2008-08-14	Astrazeneca Ab	Combination comprising ZD6474 and imatinib
GB0424339D0 (en) *	2004-11-03	2004-12-08	Astrazeneca Ab	Combination therapy
GB0519879D0 (en)	2005-09-30	2005-11-09	Astrazeneca Ab	Chemical process
PT1971338E (pt) *	2005-12-22	2011-05-09	Astrazeneca Ab	Combina??o de zd6474 e pemetrexed
US20080045589A1 (en) *	2006-05-26	2008-02-21	Susan Kelley	Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
JP2010504949A (ja) *	2006-09-29	2010-02-18	アストラゼネカアクチボラグ	Ｚｄ６４７４とベバシズマブの癌療法のための組合せ
US20080190689A1 (en) *	2007-02-12	2008-08-14	Ballard Ebbin C	Inserts for engine exhaust systems
BRPI0912170A2 (pt)	2008-05-13	2015-10-13	Astrazeneca Ab	composto, forma a, processo para a preparação da mesma, composição farmacêutica, uso de um composto, e, método para tratar um câncer em um animal de sangue quente
WO2010061208A2 (en) *	2008-11-03	2010-06-03	Astrazeneca Ab	Therapeutic treatment 555
CN106397401B (zh) *	2016-08-30	2018-11-13	山东罗欣药业集团股份有限公司	一种抗癌药物的晶体化合物及其制备方法
CN106478598B (zh) *	2016-08-30	2018-11-13	山东罗欣药业集团股份有限公司	一种凡德他尼水合物晶体及其制备方法
KR20220090431A (ko) *	2020-12-22	2022-06-29	한미약품 주식회사	Sos1 억제제로서의 신규한 퀴나졸린 유도체 화합물 및 이의 용도

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5565478A (en) *	1994-03-14	1996-10-15	The United States Of America As Represented By The Department Of Health & Human Services	Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
DE69722793T2 (de) *	1996-04-26	2004-05-19	Genaera Corp.	Squalamin in kombination mit anderen antikrebs-mittelen zur behandlung von tumoren
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
GB9727524D0 (en) *	1997-12-31	1998-02-25	Pharmacia & Upjohn Spa	Synergistic antitumor composition containing a biologically active ureido compound
US6191290B1 (en) *	1999-02-24	2001-02-20	Uab Research Foundation	Taxane derivatives for targeted therapy of cancer
ES2223705T3 (es) *	1999-04-28	2005-03-01	Board Of Regents, The University Of Texas System	Composiciones y metodos para el tratamiento de cancer mediante inhibi cion selectiva del vegf.
PL203782B1 (pl) *	1999-11-05	2009-11-30	Astrazeneca Ab	Pochodne chinazoliny,sposoby ich wytwarzania,ich kompozycje farmaceutyczne oraz ich zastosowania
TWI310684B (en) *	2000-03-27	2009-06-11	Bristol Myers Squibb Co	Synergistic pharmaceutical kits for treating cancer
GB0008269D0 (en) *	2000-04-05	2000-05-24	Astrazeneca Ab	Combination chemotherapy
WO2004014383A1 (en) *	2002-08-09	2004-02-19	Astrazeneca Ab	Combination of zd6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer
GB0218526D0 (en) *	2002-08-09	2002-09-18	Astrazeneca Ab	Combination therapy
GB0223380D0 (en) *	2002-10-09	2002-11-13	Astrazeneca Ab	Combination therapy
ATE506062T1 (de) *	2003-02-13	2011-05-15	Astrazeneca Ab	Kombinationstherapie von zd6474 mit 5-fu oder/und cpt-11
EP1648465B1 (en) *	2003-07-10	2010-08-25	AstraZeneca AB	Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
AU2005288737B2 (en) *	2004-09-27	2008-08-14	Astrazeneca Ab	Combination comprising ZD6474 and imatinib
GB0424339D0 (en) *	2004-11-03	2004-12-08	Astrazeneca Ab	Combination therapy
PT1971338E (pt) *	2005-12-22	2011-05-09	Astrazeneca Ab	Combina??o de zd6474 e pemetrexed
JP2010504949A (ja) *	2006-09-29	2010-02-18	アストラゼネカアクチボラグ	Ｚｄ６４７４とベバシズマブの癌療法のための組合せ

2001
- 2001-11-08 GB GBGB0126879.6A patent/GB0126879D0/en not_active Ceased
2002
- 2002-11-06 DE DE60213845T patent/DE60213845T2/de not_active Expired - Lifetime
- 2002-11-06 CA CA2464758A patent/CA2464758C/en not_active Expired - Fee Related
- 2002-11-06 PT PT02772624T patent/PT1446124E/pt unknown
- 2002-11-06 NZ NZ532525A patent/NZ532525A/en not_active IP Right Cessation
- 2002-11-06 EP EP02772624A patent/EP1446124B1/en not_active Expired - Lifetime
- 2002-11-06 WO PCT/GB2002/005021 patent/WO2003039551A1/en not_active Ceased
- 2002-11-06 AU AU2002337382A patent/AU2002337382B2/en not_active Ceased
- 2002-11-06 AT AT02772624T patent/ATE335488T1/de active
- 2002-11-06 US US10/494,704 patent/US20050043395A1/en not_active Abandoned
- 2002-11-06 MX MXPA04004355A patent/MXPA04004355A/es active IP Right Grant
- 2002-11-06 IL IL16174402A patent/IL161744A0/xx unknown
- 2002-11-06 JP JP2003541842A patent/JP4694127B2/ja not_active Expired - Fee Related
- 2002-11-06 BR BR0213906-5A patent/BR0213906A/pt not_active IP Right Cessation
- 2002-11-06 CN CNB028267958A patent/CN1298328C/zh not_active Expired - Fee Related
- 2002-11-06 ES ES02772624T patent/ES2269769T3/es not_active Expired - Lifetime
- 2002-11-06 KR KR1020047007020A patent/KR100959607B1/ko not_active Expired - Fee Related
- 2002-11-06 DK DK02772624T patent/DK1446124T3/da active
- 2002-11-08 AR ARP020104292A patent/AR037346A1/es not_active Application Discontinuation
2004
- 2004-05-03 IL IL161744A patent/IL161744A/en not_active IP Right Cessation
- 2004-05-06 ZA ZA200403455A patent/ZA200403455B/en unknown
- 2004-06-07 NO NO20042365A patent/NO328048B1/no not_active IP Right Cessation
2006
- 2006-11-09 CY CY20061101619T patent/CY1106259T1/el unknown
2011
- 2011-11-07 US US13/290,730 patent/US20120252827A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20050043779A (ko)	2005-05-11
EP1446124B1 (en)	2006-08-09
IL161744A0 (en)	2005-11-20
ES2269769T3 (es)	2007-04-01
HK1068546A1 (en)	2005-04-29
CN1298328C (zh)	2007-02-07
CA2464758C (en)	2010-09-28
US20120252827A1 (en)	2012-10-04
JP4694127B2 (ja)	2011-06-08
CN1612738A (zh)	2005-05-04
NO328048B1 (no)	2009-11-16
AU2002337382B2 (en)	2008-06-12
CY1106259T1 (el)	2011-06-08
BR0213906A (pt)	2004-08-31
GB0126879D0 (en)	2002-01-02
KR100959607B1 (ko)	2010-05-27
DE60213845T2 (de)	2007-03-29
CA2464758A1 (en)	2003-05-15
WO2003039551A1 (en)	2003-05-15
US20050043395A1 (en)	2005-02-24
AR037346A1 (es)	2004-11-03
MXPA04004355A (es)	2004-08-11
DK1446124T3 (da)	2006-11-13
NZ532525A (en)	2006-11-30
IL161744A (en)	2012-01-31
DE60213845D1 (de)	2006-09-21
JP2005511597A (ja)	2005-04-28
ATE335488T1 (de)	2006-09-15
EP1446124A1 (en)	2004-08-18
PT1446124E (pt)	2006-12-29
ZA200403455B (en)	2005-08-29

Legal Events

Date	Code	Title	Description
2014-06-23	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20042365L (no)	2004-06-07	Kombinasjonsterapi omfattende ZD6474 og et taxan
DK1513873T3 (da)	2014-11-03	Terapeutiske epitoper og anvendelser deraf
EP1453581A4 (en)	2007-07-11	Object recognition toys and games
GB2421695B (en)	2006-11-08	Gaming environment including portable transaction devices
DK1400518T3 (da)	2007-03-26	Heterocycliske forbindelser og lægemidler
DK1370128T3 (da)	2014-05-26	Kombineret ballepresse og ballevikler
DK1519770T3 (da)	2013-09-30	Elektroporesisk indretning og indsprøjtningsapparat
DE60144138D1 (de)	2011-04-14	Lichtemittierende Vorrichtungen und lichtemittierende Anzeigevorrichtungen
NO20035559L (no)	2004-02-16	Personlig spilleanordning
DE60230583D1 (de)	2009-02-12	Spielvorrichtung und Spielprogramm
FR2823558B1 (fr)	2005-10-21	Glaciere portable
GB0203933D0 (en)	2002-04-03	Portable dummy sterilizer
NO20034022D0 (no)	2003-09-11	En kombinasjon omfattende combretastatin og anticancermidler
GB0111505D0 (en)	2001-07-04	A portable sauna
AU148766S (en)	2002-08-05	Portable drill
NO20033709L (no)	2003-10-22	Medisinske preparater omfattende Diklofenak og Ornoprostil
NO20032821D0 (no)	2003-06-19	Sea-trosy og beslektede fremgangsmåter
SI1446124T1 (sl)	2006-12-31	Kombinacijska terapija, ki obsega ZD6474 in taksan
DE60219418D1 (de)	2007-05-24	Silanylphenole und -naphthole
TW570251U (en)	2004-01-01	Portable exercise and worship counter device
GB2380689B (en)	2004-12-29	Portable step
PL112305U1 (en)	2002-12-30	Portable game
GB0100515D0 (en)	2001-02-21	Music teaching game
SK3136U (sk)	2002-02-05	Stavebnicové prenosné minigolfové ihrisko
ITMS20010006U1 (it)	2002-02-27	Trattamento criogenico antitarlo